Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

number1 2025 Dec 05, 00:01

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

number1 2025 Dec 04, 00:00

Fed Independence on the Line? Political Influence in 2026

number1 2025 Dec 04, 00:00

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

number1 2025 Dec 03, 00:00

US Economic Outlook 2026: A Roubini Analysis

number1 2025 Dec 02, 00:01

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Frances Wang 2024 Dec 29, 16:00

Trading wisdom: how can I improve myself as a trader?

Frances Wang 2024 Dec 26, 16:00

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

Frances Wang 2024 Dec 25, 16:00

EQV stock price today: Is EQV Ventures a good investment?

Frances Wang 2024 Dec 25, 16:00

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

Frances Wang 2024 Dec 23, 16:00

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Latest news

Show more
number1 2026 Mar 14, 00:00

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

number1 2026 Mar 14, 00:00

US Economic Signals: Inflation Concerns and Growth Challenges

number1 2026 Mar 14, 00:00

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

number1 2026 Mar 14, 00:00

Apple Slashes App Store Commissions in China for Developers

number1 2026 Mar 14, 00:00

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

number1 2026 Mar 13, 12:07

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

number1 2025 Dec 06, 00:00

India's Silver Demand Surge: New Loan Framework Boosts Market

number1 2025 Dec 04, 00:00

ADP Employment Data and the Fed's Policy Path: A Closer Look

Info

Spread

2.83

Spread (%)

0.6494 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

219518222336

Shares Outstanding

540632005

Earnings Date (Next)

1999-11-22

Div Yield

2026-09-11

Ex-Dividend Date

2026-08-21

Forward annual dividend rate

10.08

Forward annual dividend yield

0.0248

EPS

16.08

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot